Rare diseases
Investigational molecules
Locations
Back to Germany22 clinical trials in Jerichow, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A Phase III Study of Lenbelintide in Adults with Obesity or Overweight and Weight‑Related Comorbidity Without Type 2 Diabetes
GermanyA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
GermanyA study testing duvakitug for patients with moderately to severely active ulcerative colitis
GermanyStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
GermanyStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
GermanyStudy of mirikizumab versus azathioprine in newly diagnosed moderate-to-severe Crohn’s disease patients
GermanyStudy of icotrokinra for adults with moderately to severely active Crohn's disease
GermanyTesting icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis
GermanyTesting benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for relief of sore throat symptoms in patients with acute pharyngitis
GermanyComparing mirikizumab versus azathioprine with glucocorticoids in newly diagnosed patients with moderate-to-severe ulcerative colitis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on Irritable Bowel Syndrome treatment using novel bacterial therapies. Research evaluates the effectiveness of living E. coli bacterial treatments in managing IBS symptoms, particularly for diarrhea-predominant cases.
Clinical investigations aim to improve patient quality of life through innovative therapeutic approaches.
Advanced research into Crohn's Disease treatment, examining new subcutaneous therapeutic options. Studies focus on evaluating the efficacy of guselkumab for patients with moderate to severe symptoms.
Research aims to establish new treatment protocols for inflammatory bowel conditions.
Comprehensive studies on chronic non-specific low back pain treatment options. Investigation of VER-01 therapy for patients who haven't responded adequately to conventional non-opioid treatments.
Research focuses on developing effective alternatives for patients with limited treatment options.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
